ArticleFrontiers in oncology2021

Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment.

Siji Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.